523 related articles for article (PubMed ID: 15795123)
1. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
[TBL] [Abstract][Full Text] [Related]
2. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease.
Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H
J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895
[TBL] [Abstract][Full Text] [Related]
3. Nadifloxacin downmodulates antigen-presenting functions of epidermal Langerhans cells and keratinocytes.
Murata K; Sugita K; Kobayashi M; Kabashima K; Tokura Y
J Dermatol Sci; 2006 May; 42(2):91-9. PubMed ID: 16431082
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL.
Graham GM; Farrar MD; Cruse-Sawyer JE; Holland KT; Ingham E
Br J Dermatol; 2004 Mar; 150(3):421-8. PubMed ID: 15030323
[TBL] [Abstract][Full Text] [Related]
5. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.
Lee YJ; Choi HJ; Kang TW; Kim HO; Chung MJ; Park YM
J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany.
Alba V; Urban E; Angeles Dominguez M; Nagy E; Nord CE; Palacín C; Vila J
Int J Antimicrob Agents; 2009 Mar; 33(3):272-5. PubMed ID: 19095414
[TBL] [Abstract][Full Text] [Related]
7. Induction of a chemoattractive proinflammatory cytokine response after stimulation of keratinocytes with Propionibacterium acnes and coproporphyrin III.
Schaller M; Loewenstein M; Borelli C; Jacob K; Vogeser M; Burgdorf WH; Plewig G
Br J Dermatol; 2005 Jul; 153(1):66-71. PubMed ID: 16029328
[TBL] [Abstract][Full Text] [Related]
8. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
Popovic S; Urbán E; Lukic M; Conlon JM
Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
[TBL] [Abstract][Full Text] [Related]
9. Antibody response to crude cell lysate of propionibacterium acnes and induction of pro-inflammatory cytokines in patients with acne and normal healthy subjects.
Basal E; Jain A; Kaushal GP
J Microbiol; 2004 Jun; 42(2):117-25. PubMed ID: 15357305
[TBL] [Abstract][Full Text] [Related]
10. Effects of bee venom against Propionibacterium acnes-induced inflammation in human keratinocytes and monocytes.
Kim JY; Lee WR; Kim KH; An HJ; Chang YC; Han SM; Park YY; Pak SC; Park KK
Int J Mol Med; 2015 Jun; 35(6):1651-6. PubMed ID: 25872535
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 secretion from CD14+ peripheral blood mononuclear cells is downregulated in patients with acne vulgaris.
Caillon F; O'Connell M; Eady EA; Jenkins GR; Cove JH; Layton AM; Mountford AP
Br J Dermatol; 2010 Feb; 162(2):296-303. PubMed ID: 19796181
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of tretinoin in combination with clindamycin.
Wauben-Penris PJ; Cerneus DP; van den Hoven WE; Leuven PJ; den Brok JH; Hall DW
J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S2-7; discussion S28-9. PubMed ID: 9891902
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties of a new undecyl-rhamnoside (APRC11) against P. acnes.
Isard O; Lévêque M; Knol AC; Ariès MF; Khammari A; Nguyen JM; Castex-Rizzi N; Dréno B
Arch Dermatol Res; 2011 Dec; 303(10):707-13. PubMed ID: 21461892
[TBL] [Abstract][Full Text] [Related]
14. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro.
Akaza N; Akamatsu H; Kishi M; Mizutani H; Ishii I; Nakata S; Matsunaga K
J Dermatol; 2009 Apr; 36(4):213-23. PubMed ID: 19348660
[TBL] [Abstract][Full Text] [Related]
15. Zinc salts inhibit in vitro Toll-like receptor 2 surface expression by keratinocytes.
Jarrousse V; Castex-Rizzi N; Khammari A; Charveron M; Dréno B
Eur J Dermatol; 2007; 17(6):492-6. PubMed ID: 17951128
[TBL] [Abstract][Full Text] [Related]
16. Influence of proinflammatory cytokines on Actinobacillus actinomycetemcomitans specific IgG responses.
Tanaka S; Fakher M; Barbour SE; Schenkein HA; Tew JG
J Periodontal Res; 2006 Feb; 41(1):1-9. PubMed ID: 16409249
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-acne actions of nadifloxacin and clindamycin that inhibit the production of sebum, prostaglandin E(2) and promatrix metalloproteinase-2 in hamster sebocytes.
Sato T; Shirane T; Noguchi N; Sasatsu M; Ito A
J Dermatol; 2012 Sep; 39(9):774-80. PubMed ID: 22394009
[TBL] [Abstract][Full Text] [Related]
18. Effects of interferons on tumour necrosis factor alpha production from human keratinocytes.
Matsuura K; Otsuka F; Fujisawa H
Cytokine; 1998 Jul; 10(7):500-5. PubMed ID: 9702413
[TBL] [Abstract][Full Text] [Related]
19. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes.
Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E
Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234
[TBL] [Abstract][Full Text] [Related]
20. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
